Tower Research Capital (TRC)’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.6K | Buy |
4,370
+3,591
| +461% | +$40.8K | ﹤0.01% | 2977 |
|
|
2025
Q1 | $5.18K | Sell |
779
-11,151
| -93% | -$74.2K | ﹤0.01% | 4146 |
|
|
2024
Q4 | $132K | Buy |
11,930
+4,918
| +70% | +$54.2K | ﹤0.01% | 1996 |
|
|
2024
Q3 | $86.2K | Buy |
7,012
+2,994
| +75% | +$36.8K | ﹤0.01% | 2339 |
|
|
2024
Q2 | $54.3K | Buy |
4,018
+1,357
| +51% | +$18.3K | ﹤0.01% | 3040 |
|
|
2024
Q1 | $35.9K | Sell |
2,661
-2,378
| -47% | -$32.1K | ﹤0.01% | 2501 |
|
|
2023
Q4 | $26.5K | Buy |
5,039
+1,298
| +35% | +$6.83K | ﹤0.01% | 3489 |
|
|
2023
Q3 | $14.7K | Sell |
3,741
-942
| -20% | -$3.71K | ﹤0.01% | 3660 |
|
|
2023
Q2 | $49.8K | Buy |
4,683
+390
| +9% | +$4.15K | ﹤0.01% | 2570 |
|
|
2023
Q1 | $36K | Sell |
4,293
-30,200
| -88% | -$253K | ﹤0.01% | 2817 |
|
|
2022
Q4 | $319K | Buy |
34,493
+31,094
| +915% | +$288K | 0.01% | 975 |
|
|
2022
Q3 | $44K | Sell |
3,399
-1,376
| -29% | -$17.8K | ﹤0.01% | 3289 |
|
|
2022
Q2 | $63K | Sell |
4,775
-4,285
| -47% | -$56.5K | ﹤0.01% | 2675 |
|
|
2022
Q1 | $190K | Buy |
9,060
+5,925
| +189% | +$124K | ﹤0.01% | 1766 |
|
|
2021
Q4 | $75K | Buy |
3,135
+1,569
| +100% | +$37.5K | ﹤0.01% | 2440 |
|
|
2021
Q3 | $40K | Sell |
1,566
-5,969
| -79% | -$152K | ﹤0.01% | 3132 |
|
|
2021
Q2 | $254K | Buy |
7,535
+5,982
| +385% | +$202K | 0.01% | 1745 |
|
|
2021
Q1 | $60K | Sell |
1,553
-446
| -22% | -$17.2K | ﹤0.01% | 2974 |
|
|
2020
Q4 | $124K | Sell |
1,999
-5,232
| -72% | -$325K | ﹤0.01% | 2147 |
|
|
2020
Q3 | $243K | Buy |
7,231
+2,527
| +54% | +$84.9K | ﹤0.01% | 2389 |
|
|
2020
Q2 | $112K | Buy |
+4,704
| New | +$112K | ﹤0.01% | 2359 |
|